Quick Takeaways
- ZLAB - Zai Lab Ltd has 19 insiders with reported activity on this page.
- Net insider value flow over the last year: -$21,988,679.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 19 Insiders of Zai Lab Ltd
- Symbol
- ZLAB on Nasdaq
- Location
- Shanghai
What Changed
- Buy value: $321,833; sell value: $22,310,512.
- Net share flow: -805,529.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$21,988,679.
Buys
$321,833
Shares: 11,731
Insiders: 2
Sells
$22,310,512
Shares: 817,260
Insiders: 7
Net
-$21,988,679
Shares: -805,529
Insiders: -5
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 1,731 | 279,522 | $32,733 | $5,397,538 | -$5,364,805 |
| 3-6 | 0 | 34,006 | $0 | $626,164 | -$626,164 |
| 6-9 | 10,000 | 213,901 | $289,100 | $7,446,541 | -$7,157,441 |
| 9-12 | 0 | 289,831 | $0 | $8,840,269 | -$8,840,269 |
Zai Lab Ltd executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Du Ying | Chairperson & CEO, Director | $23,625,893 | -$17,891,623 | -43% | Mixed | 06 Apr 2026 |
| Fu Tao | President & COO, Director | $13,303,479 | Mixed | 28 Oct 2021 | ||
| WIRTH PETER | Director | $8,169,424 | Mixed | 18 Jun 2025 | ||
| Joshua L. Smiley | President and Chief Operating Officer | $2,877,838 | -$245,887 | -7.9% | Mixed | 06 Apr 2026 |
| Alan B. Sandler | Head of Global Dev., Oncology | $1,906,906 | Mixed | 25 Jun 2022 | ||
| John D. Diekman | Director | $1,897,457 | Mixed | 18 Jun 2025 | ||
| Harald Reinhart | President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases | $1,774,330 | Mixed | 25 Jun 2024 | ||
| William Ki Chul Cho | Chief Financial Officer | $1,603,316 | Mixed | 03 Apr 2023 | ||
| Rafael Amado | President, Head of Global Oncology Research and Development | $1,552,994 | -$779,994 | -33% | Mixed | 06 Apr 2026 |
| Leon O Moulder Jr. | Director | $1,317,860 | Mixed | 18 Jun 2025 | ||
| William Lis | Director | $1,252,231 | -$492,745 | -28% | Filing P/S | 18 Jun 2025 |
| Richard Gaynor | Director | $1,070,873 | +$32,733 | +3.2% | Filing P/S | 17 Mar 2026 |
| Kai-Xian Chen | Director | $1,038,757 | Mixed | 31 Dec 2024 | ||
| Michel Vounatsos | Director | $844,530 | Mixed | 18 Jun 2025 | ||
| Yi Liang | CCO & President, Greater China | $817,619 | Mixed | 25 Jun 2022 | ||
| Yajing Chen | Chief Financial Officer | $813,843 | -$752,659 | -48% | Mixed | 06 Apr 2026 |
| Frazor Titus Edmondson III | Chief Legal Officer | $810,953 | -$1,143,418 | -59% | Mixed | 06 Apr 2026 |
| Scott W. Morrison | Director | $712,171 | -$715,086 | -50% | Mixed | 18 Jun 2025 |
| Nisa Leung | Director | Mixed | 18 Jun 2025 |
Top shareholders of Zai Lab Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Qiming Venture Partners IV, L.P. |
13D/G
|
Qiming Corporate GP IV, Ltd. |
6%
|
66,329,320
|
$2,365,303,551 | $0 | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13D/G
13F
|
Company |
6.3%
|
69,590,320
|
$1,258,888,889 | +$844,379,694 | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
5.2%
|
57,435,330
|
$1,083,804,677 | $0 | 30 Mar 2026 | |
| Qiming Corporate GP IV, Ltd |
13D/G
|
— |
4.4%
|
48,883,643
|
$884,305,102 | $0 | 31 Dec 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.17%
|
1,902,320
|
$33,556,925 | — | 31 Dec 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.16%
|
1,808,035
|
$31,893,740 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
1,782,252
|
$31,438,925 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
1,687,846
|
$29,773,604 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
1,440,406
|
$25,408,762 | — | 31 Dec 2025 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.13%
|
1,418,005
|
$25,013,608 | — | 31 Dec 2025 | |
| Du Ying |
3/4/5
|
Chairperson & CEO, Director |
—
mixed-class rows
|
1,515,135
mixed-class rows
|
$23,625,893 | -$17,891,623 | 06 Apr 2026 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.11%
|
1,246,520
|
$21,988,613 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.07%
|
811,546
|
$14,315,671 | — | 31 Dec 2025 | |
| Fu Tao |
3/4/5
|
President & COO, Director |
—
class O/S missing
|
265,168
|
$13,303,479 | — | 28 Oct 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
4.3%
from 13D/G
|
752,858
|
$13,280,417 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.06%
|
635,213
|
$11,205,157 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
602,954
|
$10,637,000 | — | 31 Dec 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.05%
|
510,000
|
$8,996,000 | — | 31 Dec 2025 | |
| WIRTH PETER |
3/4/5
|
Director |
—
class O/S missing
|
393,750
|
$8,169,424 | — | 18 Jun 2025 | |
| B Group, Inc. |
13F
|
Company |
0.04%
|
400,000
|
$7,056,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
388,769
|
$6,857,886 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.04%
|
387,800
|
$6,842,649 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
382,062
|
$6,739,574 | — | 31 Dec 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.03%
|
373,399
|
$6,586,758 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.03%
|
299,844
|
$5,286,250 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
293,703
|
$5,180,921 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
289,705
|
$5,110,397 | — | 31 Dec 2025 | |
| NAN FUNG TRINITY (HK) Ltd |
13F
|
Company |
0.02%
|
269,975
|
$4,762,359 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.02%
|
238,609
|
$4,209,063 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
231,802
|
$4,088,987 | — | 31 Dec 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.02%
|
204,982
|
$3,615,882 | — | 31 Dec 2025 | |
| XY Capital Ltd |
13F
|
Company |
0.02%
|
202,304
|
$3,568,643 | — | 31 Dec 2025 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.02%
|
196,853
|
$3,472,487 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.02%
|
181,133
|
$3,195,186 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
173,946
|
$3,068,352 | — | 31 Dec 2025 | |
| Campbell & CO Investment Adviser LLC |
13F
|
Company |
0.02%
|
170,117
|
$3,000,864 | — | 31 Dec 2025 | |
| NEXTBio Capital Management LP |
13F
|
Company |
0.01%
|
163,362
|
$2,881,706 | — | 31 Dec 2025 | |
| Joshua L. Smiley |
3/4/5
|
President and Chief Operating Officer |
—
mixed-class rows
|
246,584
mixed-class rows
|
$2,877,838 | -$245,887 | 06 Apr 2026 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
151,318
|
$2,669,246 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
149,434
|
$2,636,016 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
136,428
|
$2,406,590 | — | 31 Dec 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.01%
|
132,189
|
$2,331,814 | — | 31 Dec 2025 | |
| Alan B. Sandler |
3/4/5
|
Head of Global Dev., Oncology |
—
class O/S missing
|
73,000
|
$1,906,906 | — | 25 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
107,651
|
$1,898,964 | — | 31 Dec 2025 | |
| John D. Diekman |
3/4/5
|
Director |
—
class O/S missing
|
99,769
|
$1,897,457 | — | 18 Jun 2025 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
103,118
|
$1,819,001 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.01%
|
101,782
|
$1,795,434 | — | 31 Dec 2025 | |
| Harald Reinhart |
3/4/5
|
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases |
—
mixed-class rows
|
206,440
mixed-class rows
|
$1,774,330 | — | 25 Jun 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.01%
|
97,500
|
$1,719,900 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
96,442
|
$1,701,237 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Zai Lab Ltd
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Joshua L. Smiley | ZLAB | American Depositary Shares | Sale | -2.5% | $61,692 | $20.45 | -3,017 | 117,602 | 06 Apr 2026 | Direct |
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Sale | -4.98% | $25,028 | $20.45 | -1,224 | 23,366 | 06 Apr 2026 | Direct |
| Du Ying | ZLAB | American Depositary Shares | Sale | -0.24% | $54,249 | $20.45 | -2,653 | 1,122,626 | 06 Apr 2026 | Direct |
| Yajing Chen | ZLAB | American Depositary Shares | Sale | -2.62% | $17,442 | $20.45 | -853 | 31,705 | 06 Apr 2026 | Direct |
| Rafael Amado | ZLAB | American Depositary Shares | Sale | -4.58% | $56,007 | $20.45 | -2,739 | 57,022 | 06 Apr 2026 | Direct |
| Joshua L. Smiley | ZLAB | American Depositary Shares | Sale | -7.38% | $196,029 | $20.39 | -9,614 | 120,619 | 02 Apr 2026 | Direct |
| Joshua L. Smiley | ZLAB | American Depositary Shares | Options Exercise | 5.8% | 7,145 | 130,233 | 02 Apr 2026 | Direct | ||
| Joshua L. Smiley | ZLAB | Restricted Share Units | Options Exercise | -50% | -7,145 | 7,145 | 02 Apr 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Sale | -14.6% | $85,516 | $20.39 | -4,194 | 24,590 | 02 Apr 2026 | Direct |
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Options Exercise | 21.2% | 5,031 | 28,784 | 02 Apr 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | Restricted Share Units | Options Exercise | -50% | -5,031 | 5,032 | 02 Apr 2026 | Direct | ||
| Du Ying | ZLAB | American Depositary Shares | Sale | -0.49% | $113,695 | $20.39 | -5,576 | 1,125,279 | 02 Apr 2026 | Direct |
| Du Ying | ZLAB | American Depositary Shares | Options Exercise | 0.6% | 6,750 | 1,130,855 | 02 Apr 2026 | Direct | ||
| Du Ying | ZLAB | Restricted Share Units | Options Exercise | -33.3% | -6,750 | 13,500 | 02 Apr 2026 | Direct | ||
| Yajing Chen | ZLAB | American Depositary Shares | Sale | -13.8% | $106,008 | $20.39 | -5,199 | 32,558 | 02 Apr 2026 | Direct |
| Yajing Chen | ZLAB | American Depositary Shares | Options Exercise | 7.09% | 2,500 | 37,757 | 02 Apr 2026 | Direct | ||
| Yajing Chen | ZLAB | Restricted Share Units | Options Exercise | -50% | -2,500 | 2,500 | 02 Apr 2026 | Direct | ||
| Rafael Amado | ZLAB | American Depositary Shares | Sale | -14.2% | $202,065 | $20.39 | -9,910 | 59,761 | 02 Apr 2026 | Direct |
| Rafael Amado | ZLAB | American Depositary Shares | Options Exercise | 8.39% | 5,391 | 69,671 | 02 Apr 2026 | Direct | ||
| Rafael Amado | ZLAB | Restricted Share Units | Options Exercise | -50% | -5,391 | 5,391 | 02 Apr 2026 | Direct | ||
| Joshua L. Smiley | ZLAB | American Depositary Shares | Options Exercise | 35.2% | 32,062 | 123,088 | 01 Apr 2026 | Direct | ||
| Joshua L. Smiley | ZLAB | Restricted Share Units | Options Exercise | -33.3% | -32,062 | 64,125 | 01 Apr 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Options Exercise | 265.8% | 17,259 | 23,753 | 01 Apr 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | Restricted Share Units | Options Exercise | -100% | -17,259 | 0 | 01 Apr 2026 | Direct | ||
| Du Ying | ZLAB | American Depositary Shares | Options Exercise | 1.28% | 14,200 | 1,124,105 | 01 Apr 2026 | Direct | ||
| Du Ying | ZLAB | Restricted Share Units | Options Exercise | -100% | -14,200 | 0 | 01 Apr 2026 | Direct | ||
| Yajing Chen | ZLAB | American Depositary Shares | Options Exercise | 76.3% | 15,258 | 35,257 | 01 Apr 2026 | Direct | ||
| Yajing Chen | ZLAB | Restricted Share Units | Options Exercise | -91% | -15,258 | 1,500 | 01 Apr 2026 | Direct | ||
| Rafael Amado | ZLAB | American Depositary Shares | Options Exercise | 43.6% | 19,523 | 64,280 | 01 Apr 2026 | Direct | ||
| Rafael Amado | ZLAB | Restricted Share Units | Options Exercise | -33.3% | -19,523 | 39,046 | 01 Apr 2026 | Direct | ||
| Richard Gaynor | ZLAB | American Depositary Shares | Purchase | 3.15% | $32,733 | $18.91 | 1,731 | 56,630 | 17 Mar 2026 | Direct |
| Joshua L. Smiley | ZLAB | American Depositary Shares | Sale | -2.11% | $36,623 | $18.63 | -1,966 | 91,026 | 13 Mar 2026 | Direct |
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Sale | -16.5% | $23,862 | $18.63 | -1,281 | 6,494 | 13 Mar 2026 | Direct |
| Yajing Chen | ZLAB | American Depositary Shares | Sale | -7.85% | $31,723 | $18.63 | -1,703 | 19,999 | 13 Mar 2026 | Direct |
| Rafael Amado | ZLAB | American Depositary Shares | Sale | -6.2% | $55,083 | $18.63 | -2,957 | 44,757 | 13 Mar 2026 | Direct |
| Joshua L. Smiley | ZLAB | American Depositary Shares | Options Exercise | 7.38% | 6,388 | 92,992 | 12 Mar 2026 | Direct | ||
| Joshua L. Smiley | ZLAB | Restricted Share Units | Options Exercise | -25% | -6,388 | 19,165 | 12 Mar 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | American Depositary Shares | Options Exercise | 121.1% | 4,258 | 7,775 | 12 Mar 2026 | Direct | ||
| Frazor Titus Edmondson III | ZLAB | Restricted Share Units | Options Exercise | -25% | -4,258 | 12,777 | 12 Mar 2026 | Direct | ||
| Yajing Chen | ZLAB | American Depositary Shares | Options Exercise | 24.4% | 4,258 | 21,702 | 12 Mar 2026 | Direct | ||
| Yajing Chen | ZLAB | Restricted Share Units | Options Exercise | -25% | -4,258 | 12,777 | 12 Mar 2026 | Direct | ||
| Rafael Amado | ZLAB | American Depositary Shares | Options Exercise | 12.6% | 5,323 | 47,714 | 12 Mar 2026 | Direct | ||
| Rafael Amado | ZLAB | Restricted Share Units | Options Exercise | -25% | -5,323 | 15,971 | 12 Mar 2026 | Direct | ||
| Du Ying | ZLAB | Restricted Share Units | Award | 32,419 | 32,419 | 11 Mar 2026 | Direct | |||
| Du Ying | ZLAB | Stock Options (Right to Buy) | Award | 353,430 | 353,430 | 11 Mar 2026 | Direct | |||
| Du Ying | ZLAB | American Depositary Shares | Sale | -0.1% | $20,363 | $19.08 | -1,067 | 1,109,905 | 11 Mar 2026 | Direct |
| Du Ying | ZLAB | American Depositary Shares | Tax liability | -9.54% | -116,936 | 1,108,317 | 10 Mar 2026 | Direct | ||
| Du Ying | ZLAB | American Depositary Shares | Options Exercise | 27.4% | 263,747 | 1,225,253 | 10 Mar 2026 | Direct | ||
| Du Ying | ZLAB | Restricted Share Units | Options Exercise | -25% | -2,655 | 7,965 | 10 Mar 2026 | Direct | ||
| Du Ying | ZLAB | Stock Options (Right to Buy) | Options Exercise | -36.2% | -261,092 | 461,092 | 10 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.